Sole 0 4 0 4 B-contraception_consent
reliance 5 13 5 13 I-contraception_consent
on 14 16 14 16 I-contraception_consent
oral 17 21 17 21 I-contraception_consent
contraceptives 22 36 22 36 I-contraception_consent
( 37 38 37 38 I-contraception_consent
OCPs 38 42 38 42 I-contraception_consent
) 42 43 42 43 I-contraception_consent
for 44 47 44 47 O
birth 48 53 48 53 O
control 54 61 54 61 O

Subject 0 7 62 69 O
has 8 11 70 73 O
a 12 13 74 75 O
concomitant 14 25 76 87 B-chronic_disease
disease 26 33 88 95 I-chronic_disease
or 34 36 96 98 O
condition 37 46 99 108 O
that 47 51 109 113 O
could 52 57 114 119 O
interfere 58 67 120 129 O
with 68 72 130 134 O
, 72 73 134 135 O
or 74 76 136 138 O
for 77 80 139 142 O
which 81 86 143 148 O
treatment 87 96 149 158 O
could 97 102 159 164 O
interfere 103 112 165 174 O
with 113 117 175 179 O
, 117 118 179 180 O
the 119 122 181 184 O
conduct 123 130 185 192 O
of 131 133 193 195 O
the 134 137 196 199 O
study 138 143 200 205 O
, 143 144 205 206 O
or 145 147 207 209 O
could 148 153 210 215 O
in 154 156 216 218 O
the 157 160 219 222 O
opinion 161 168 223 230 O
of 169 171 231 233 O
the 172 175 234 237 O
investigator 176 188 238 250 O
increase 189 197 251 259 O
the 198 201 260 263 O
risk 202 206 264 268 O
of 207 209 269 271 O
AEs 210 213 272 275 O
during 214 220 276 282 O
the 221 224 283 286 O
subject 225 232 287 294 O
's 232 234 294 296 O
participation 235 248 297 310 O
in 249 251 311 313 O
the 252 255 314 317 O
study 256 261 318 323 O

Subject 0 7 324 331 O
has 8 11 332 335 O
acute 12 17 336 341 B-chronic_disease
diarrhea 18 26 342 350 I-chronic_disease
within 27 33 351 357 O
7 34 35 358 359 B-upper_bound
days 36 40 360 364 I-upper_bound
prior 41 46 365 370 I-upper_bound
to 47 49 371 373 O
enrollment 50 60 374 384 O

Subject 0 7 385 392 O
is 8 10 393 395 O
at 11 13 396 398 O
least 14 19 399 404 O
18 20 22 405 407 B-lower_bound
years 23 28 408 413 I-lower_bound
of 29 31 414 416 O
age 32 35 417 420 B-age

Subject 0 7 421 428 O
is 8 10 429 431 O
currently 11 20 432 441 O
taking 21 27 442 448 O
or 28 30 449 451 O
plans 31 36 452 457 O
to 37 39 458 460 O
take 40 44 461 465 O
during 45 51 466 472 O
deployment 52 62 473 483 O
at 63 65 484 486 O
least 66 71 487 492 O
one 72 75 493 496 B-lower_bound
of 76 78 497 499 O
the 79 82 500 503 O
following 83 92 504 513 O
medications 93 104 514 525 B-treatment

Subject 0 7 526 533 O
received 8 16 534 542 O
any 17 20 543 546 O
systemic 21 29 547 555 B-treatment
or 30 32 556 558 I-treatment
gastrointestinal 33 49 559 575 I-treatment
antibiotic 50 60 576 586 I-treatment
in 61 63 587 589 O
the 64 67 590 593 O
7 68 69 594 595 B-upper_bound
days 70 74 596 600 I-upper_bound
prior 75 80 601 606 I-upper_bound
to 81 83 607 609 O
enrollment 84 94 610 620 O

Subject 0 7 621 628 O
's 7 9 628 630 O
duration 10 18 631 639 O
of 19 21 640 642 O
prophylaxis 22 33 643 654 B-treatment
will 34 38 655 659 O
be 39 41 660 662 O
least 42 47 663 668 O
2 48 49 669 670 B-lower_bound
weeks 50 55 671 676 I-lower_bound

The 0 3 677 680 O
pregnancy 4 13 681 690 B-pregnancy
outcome 14 21 691 698 O
will 22 26 699 703 O
be 27 29 704 706 O
followed 30 38 707 715 O
per 39 42 716 719 O
IRB 43 46 720 723 O
and 47 50 724 727 O
other 51 56 728 733 O
regulatory 57 67 734 744 O
requirements 68 80 745 757 O
for 81 84 758 761 O
US 85 87 762 764 O
and 88 91 765 768 O
UK 92 94 769 771 O
personnel 95 104 772 781 O

Women 0 5 782 787 B-gender
: 5 6 787 788 O
Non 7 10 789 792 O
- 10 11 792 793 O
nursing 11 18 793 800 O
and 19 22 801 804 O
negative 23 31 805 813 B-pregnancy
urine 32 37 814 819 I-pregnancy
/ 37 38 819 820 I-pregnancy
serum 38 43 820 825 I-pregnancy
pregnancy 44 53 826 835 I-pregnancy
test 54 58 836 840 O
with 59 63 841 845 O
understanding 64 77 846 859 O
( 78 79 860 861 O
through 79 86 861 868 O
informed 87 95 869 877 O
consent 96 103 878 885 O
process 104 111 886 893 O
) 111 112 893 894 O
to 113 115 895 897 O
avoid 116 121 898 903 O
pregnancy 122 131 904 913 O
while 132 137 914 919 O
on 138 140 920 922 O
study 141 146 923 928 O
drug 147 151 929 933 O

allergy 0 7 934 941 O
to 8 10 942 944 O
rifaximin 11 20 945 954 B-allergy_name
or 21 23 955 957 O
rifampicin 24 34 958 968 B-allergy_name

anti 0 4 969 973 B-treatment
- 4 5 973 974 I-treatment
malarial 5 13 974 982 I-treatment
prophylaxis 14 25 983 994 I-treatment
agents 26 32 995 1001 I-treatment

available 0 9 1002 1011 O
for 10 13 1012 1015 O
the 14 17 1016 1019 O
end 18 21 1020 1023 O
of 22 24 1024 1026 O
study 25 30 1027 1032 O
visits 31 37 1033 1039 O
and 38 41 1040 1043 O
sample 42 48 1044 1050 O
collection 49 59 1051 1061 O
at 60 62 1062 1064 O
COO 63 66 1065 1068 O
( 67 68 1069 1070 O
within 68 74 1070 1076 O
6 75 76 1077 1078 B-upper_bound
months 77 83 1079 1085 I-upper_bound
from 84 88 1086 1090 O
start 89 94 1091 1096 O
of 95 97 1097 1099 O
prophylaxis 98 109 1100 1111 B-treatment
) 109 110 1111 1112 O

theophylline 0 12 1113 1125 B-treatment

warfarin 0 8 1126 1134 B-treatment
( 9 10 1135 1136 I-treatment
Coumadin 10 18 1136 1144 I-treatment
) 18 19 1144 1145 I-treatment

